TOP TRENDING

US FINALLY approves Pfizer's COVID-19 vaccine


Donald Trump hailed the FDA's approval of the coronavirus vaccine as a "medical miracle" on Friday night – and said the drug will "save millions of lives and end the pandemic once and for all".

According to the president, millions of doses of the COVID-19 vaccine are being shipped to the US by Pfizer. According to the president, the first vaccinations should be given within 24 hours.

"This is one of the greatest scientific achievements in history," Trump said in a White House video statement, adding that it was a "medical miracle". "I am pleased to announce that the FDA has approved the Phizer vaccine."

He added that the shock was "very safe" after meeting the gold standard of safety.

'The first vaccine will be given in less than 24 hours. The governors decide where the vaccines go. We want our seniors, healthcare workers and first responders to come first, ”he added.

Congress and President Donald Trump have already passed laws requiring the vaccines to be free for all Americans.

Pfizer's vaccine was approved by regulators in an emergency late Friday after the Trump administration urged regulators to act quickly.

White House Chief of Staff Mark Meadows reportedly even told FDA Commissioner Dr. Stephen Hahn should consider getting a new job if he doesn't approve the vaccine on Friday, a senior administration official told the New York Times.

Dr. Hahn then ordered the agency's vaccine regulators to approve it by the end of the day.

Approval was granted no more than 24 hours after a committee of experts announced approval of the shot, which aroused criticism from Trump himself and alleged threats from his chief of staff.

An estimated 2.9 million doses of Pfizer's vaccine are expected to be shipped to all US states and territories in the next 24 hours.

It is up to the states to decide who to vaccinate first, but the CDC has recommended injecting healthcare workers and nursing home residents (who have equal priority) first.

Donald Trump hailed the FDA's approval of the coronavirus vaccine as a "medical miracle" on Friday night – and said the drug will "save millions of lives and end the pandemic once and for all".

Pfizer's vaccine was approved as an emergency by the FDA on Friday night. It's the first US-approved shot, and the first 2.9 million doses are expected to be shipped within 24 hours, but will likely not be injected into the arms of high-priority healthcare and nursing home workers until Monday or Tuesday, so HHS officials said earlier on Friday

Pfizer's vaccine was approved as an emergency by the FDA on Friday night. It's the first US-approved shot, and the first 2.9 million doses are expected to be shipped within 24 hours, but will likely not be injected into the arms of high-priority healthcare and nursing home workers until Monday or Tuesday, so HHS officials said earlier on Friday

The Department of Health and Human Services said Friday morning that the first Americans would be vaccinated Monday or Tuesday. At the time, Secretary Alex Azar expected the vaccine to be approved within "a few days," he said on Good Morning America.

But President Trump urged the FD to speed up its approval and hurled insults at regulators. He called the agency a "big, old, slow turtle" as hours had passed after the FDA's panel of experts announced it would approve the vaccine.

The UK and Canada have already approved Pfizer's shot, and the first Brits received their first of two cans on Tuesday.

Extending the approval time is not expected to extend the length of time it takes for Americans to inject, HHS sources told the New York Times.

White House Chief of Staff Mark Meadows reportedly also said FDA Commissioner Dr. Stephen Hahn to approve the shot or submit his resignation today, sources told the Washington Post.

Hahn confirmed he had spoken to the White House, but denied the threat.

The Pfizer vaccine approval marks a historic step in containing the pandemic and comes at the end of America's deadliest week since the first COVID-19 case in January 2020. In the past seven days, nearly 16,000 people have died from Coronavirus COVID tracking project . The total number of US infections is nearly 16 million.

Obtaining an emergency permit to vaccinate Americans aged 16 and over is a critical step, but there are still many challenges ahead. Pfizer's 95 percent effective vaccine must be stored in extremely cold temperatures, raising concerns that shipping may take longer or accidents in the complicated administration process can ruin valuable doses.

Approval comes at the end of the deadliest week of the pandemic in the US. In the past seven days, nearly 16 million Americans have died from COVID-19 (red), and the total number of infections is approaching 16 million (green).

Approval comes at the end of the deadliest week of the pandemic in the US. In the past seven days, nearly 16 million Americans have died from COVID-19 (red), and the total number of infections is approaching 16 million (green).

Already due to supply chain problems, the company had to reduce its planned global sales for 2020 from 100 million to 50 million.

The U.S. has a total of 100 million cans in a contract with the option to buy more, but the Trump administration reportedly turned down Pfizer's offer to buy more earlier this year. Other countries have increased their doses so the US may struggle to purchase more in the coming months.

An FDA panel of experts recommended that the agency grant Pfizer's emergency firing clearance on Thursday evening after nine hours of deliberation.

17 of the 23 were in favor of allowing the shot, despite concerns about reports of anaphylactic shock and severe allergic reactions among two UK health workers with a history of food and drug allergies. Some were also skeptical that Pfizer hadn't tested the shot in enough minorities or 16- and 17-year-olds.

The panel's approval was far from a guarantee that the vaccine would be approved.

As a result, many Americans, including, and most importantly, President Trump were angry when Secretary Azar said it could take days for the FDA to issue an emergency clearance (a form of temporary approval with a bottom bar to prove it works and safe is what the regulators give in special circumstances like the pandemic).

According to the Washington Post, the FDA commissioner's job was even at stake after Mark Meadows allegedly told him to approve the vaccine on Friday or to file his resignation.

Pfizer has signed a $ 1.95 billion contract with the U.S. government to provide 100 million doses of its coronavirus vaccine to Americans

Pfizer has signed a $ 1.95 billion contract with the U.S. government to provide 100 million doses of its coronavirus vaccine to Americans

"This is an untrue representation of the telephone conversation with the chief of staff," he said NBC News.

& # 39; The FDA was encouraged to continue working expeditiously on Pfizer-BioNTech's EEA request. The FDA is keen to get this approval swiftly. & # 39;

According to anonymous sources quoted by the New York Times, the staff spent Friday completing the paperwork and they will be done by the end of the day.

Previously, Trump raged in the administration and asked them to "stop playing games and save lives".

The Secretary for Health and Human Services (HHS), Alex Azar, had said official approval could take "a few more days".

Following Trump's Twitter warning, HHS said the vaccine would be approved by Friday night, not Saturday.

A panel of 23 independent scientists voted in favor of the vaccine Thursday and recommended it to the FDA after a day of lengthy discussion about whether or not it is safe.

Vaccines will be shipped to all US states and territories within 24 hours of FDA emergency clearances, as Operation Warp Speed ​​officials promised.

However, it wasn't clear whether Friday night approval will result in vaccines reaching Americans earlier, according to the Times sources.

Scroll down for video

The White House urged Dr. Stephen Hahn, FDA commissioner (right), to approve or submit his letter of resignation today for Pfizer's coronavirus vaccine. It came after President Trump (center) beat up the agency as an "old, slow turtle" on Friday

The White House urged Dr. Stephen Hahn, FDA commissioner (right), to approve or submit his letter of resignation today for Pfizer's coronavirus vaccine. It came after President Trump (center) beat up the agency as an "old, slow turtle" on Friday

Alex Azar said of Good Morning America, Health and Human Services that the FDA has notified Pfizer that it intends to approve its COVID vaccine after an excruciating two and a half week wait, but inexplicably still not

Alex Azar said of Good Morning America, Health and Human Services that the FDA has notified Pfizer that it intends to approve its COVID vaccine after an excruciating two and a half week wait, but inexplicably still not

SCHEDULE ON PFIZER Vaccine

November 18: Pfizer announces its vaccine is 94% effective

November 23: Pfizer is submitting trial data to the FDA for emergency approval

3rd of December: UK approves Pfizer vaccine

December 7th: The first doses are given in England

December 8th: The FDA publishes a preliminary analysis stating the vaccine is safe and effective but has not yet been approved

9th of December: Canada approves the vaccine

9th of December: Deadliest day for the US with 3,045 deaths

10th of December: The FDA advisory panel meets to discuss the vaccine. Vaccine is approved.

According to the CDC, the shots should go to health care workers and long-term care facilities first. Elderly prisoners in long-term care facilities operated by correctional units are enrolled in the first wave of vaccinations under CDC guidance.

But in the end it will be up to whichever state is vaccinated first. Some, including Massachusetts and New Mexico, will include inmates in their first round of vaccination.

Most governors expect their first shipments to run out within days of their arrival. This could happen on Monday, they told Operation Warp Speed.

The first Americans will have "gun shots" within 96 hours (four days) of emergency clearance, said General Gustave Perna, co-head of the US vaccine initiative.

However, the FDA has not yet officially granted approval, and the first doses have not yet been distributed, despite both the UK and Canada having given the green light.

Health and Personal Services Alex Azar said the FDA has told Pfizer that it intends to approve its COVID vaccine after an excruciating two and a half week wait, but inexplicably it still has not and there is still no appointment for the first People will get it in America.

Keep talking Good morning Americahe said: & # 39; I have good news for you. The FDA recently informed Pfizer that it intends to proceed with approval for the vaccine.

"Over the next few days, probably while we are negotiating with Pfizer about the information doctors need to adequately prescribe, we should see the approval and work with Pfizer to send it out so we can see people getting vaccinated Monday, Tuesday the next week. & # 39;

The first shots in the US will not be fired before Monday or Tuesday. Upstairs someone getting the vaccine in the UK on December 8th

The first shots in the US will not be fired before Monday or Tuesday. Upstairs someone getting the vaccine in the UK on December 8th

The United States has had its deadliest week of the coronavirus pandemic, with deaths rising 44 percent across the country from last week

Hours later, following President Trump's angry tweets, HHS officials said the hour had been moved to Friday night.

PFIZER AND MODERNA WILL BRING COVID VACCINE SALES worth $ 32 billion in 2021, analysts say

By Keith Griffith

Wall Street analysts have forecast that Pfizer and Moderna will collectively raise $ 32 billion from COVID-19 vaccine sales over the next year.

Pfizer's vaccine, which passed a key FDA panel on Thursday, is expected to generate $ 19 billion in sales in 2021, on top of the estimated $ 975 million this year, according to Morgan Stanley.

Goldman Sachs estimates Moderna will have vaccine sales of $ 13.2 billion next year, according to CNN. It's a staggering sum for the little-known company that had sales of just $ 60 million last year and has never licensed a product.

Meanwhile, Johnson & Johnson and AstraZeneca, which have vaccines in the trial phase, have both promised to make their vaccines available for no profit once approved.

Pfizer will also share 50 percent of all vaccine revenues with German partner BioNtech, who worked together to develop the vaccine.

That said, Americans could get vaccines as early as Monday.

Once distributed to the states, each state must draw up its own schedule and plan to distribute it among the people.

The FDA released a statement Friday morning claiming it was working to get the vaccine approved quickly.

& # 39; Following yesterday's positive outcome from the Advisory Committee meeting regarding the Pfizer-BioNTech COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it is expediting the completion and approval of the will work towards the emergency.

"The agency has also notified the US Centers for Disease Control, Prevention and Operation Warp Speed ​​so that they can implement their plans for timely vaccine distribution," said Commissioner Steve Hahn in a statement Friday morning.

Pfizer is expected to ship 2.9 million doses of its vaccine once approved.

Sales are slated to begin within 24 hours of the FDA launch.

According to Operation Warp Speed, the cans will be distributed to all 50 states and all US territories within this period.

Pfizer, a $ 16 billion company, is distributing its own vaccine using special boxes packed with dry ice to keep the shot at the required -94 degrees Fahrenheit.

The boxes are delivered by Fedex and UPS.

Pfizer has signed a $ 1.95 billion deal with the United States for 100 million rounds of Doss.

Both it and Moderna – whose shot is under review by the FDA advisory panel on Dec. 17 – plan to sell their vaccines for a profit.

The two companies are said to collectively earn $ 32 billion from their vaccines in the next year alone, a Wall Street analyst project.

In New York, for example, Governor Cuomo says he will begin distributing the shots on December 15, starting with nursing home staff, residents and health care workers.

PRISONS ARE FIRST TO RECEIVE COVID-19 VACCINES IN AT LEAST 9 STATES

Prisoners, people in homeless shelters, and medical workers will be the first to receive COVID-19 vaccination in Massachusetts, in front of the elderly and the public.

The state's three-phase distribution plan was drawn up on Wednesday and prioritizes healthcare workers, first responders and community workers such as prisons and shelters from December to February.

In the second phase, from February to April, people at high risk of COVID-19 complications, school teachers, sanitation and public works workers, and adults over 65 years of age will receive the vaccine.

In the third phase, from April to June, the vaccine will be available to the public.

Each state will set its own distribution plans, and at least nine states – Massachusetts, Connecticut, Delaware, Maryland, Nebraska, North Carolina, Montana, Nevada, New Mexico – and Puerto Rico will give inmates first access to the vaccine, according to the Washington Post.

Prisons across the country have experienced massive COVID-19 outbreaks due to crowded conditions, shared bathrooms, and communal facilities, making social distancing virtually impossible.

More than 252,000 inmates are infected with COVID-19, and at least 1,450 inmates and correctional officers have died from the contagious virus, according to a database from the New York Times.

Around 2.3 million people are incarcerated in prisons and detention centers in the United States. Nearly 500,000 of them have not been convicted of a crime or awaiting trial, according to the Prison Policy Initiative.

Azar said the first shots in the arm would be on December 14 or 15.

“We see 20 million Americans being vaccinated in the next few weeks, 50 million by the end of January.

“We believe we can have 100 million vaccinations by the end of February.

"The products will continue to roll out, especially when we can add AstraZeneca and Johnson & Johnson to our arsenal," he said.

Optimistically, that would mean less than a third of the US population would be vaccinated by the end of February.

However, all experts say that at least 70 percent of the population must be vaccinated in order for life to return to pre-pandemic levels, and there is no telling how long that will take or if it will ever take.

The vaccine that scientists are now trying to fight is still very skeptical.

On Friday morning, former CDC director Dr. Rich Besser today: “There was an overwhelming feeling that this is a very safe and effective vaccine and that the FDA should approve it.

The scientists on yesterday's panel also all voted that the vaccine was safe.

'An EEA is a starting point, but in all likelihood the FDA will ask the company to conduct further studies.

"There was an overwhelming feeling that this is a very safe and effective vaccine and that the FDA should approve it," he said.

He went on to say there were concerns about the fact that it had been introduced quickly and said the FDA would likely ask Pfizer to continue investigating the study participants for more information.

“We have never got a vaccine approved so quickly, and that will worry a lot of people. These concerns need to be addressed.

"You won't be able to address these concerns by just running ads that say," Everyone is getting this vaccine. "

“It will cost federal dollars so that communities and states can work with everyone to understand what the concerns of the people are, who are the trusted leaders in each community, and what needs to be done.

"This is approved based on two months of safety data, which is not a lot. As we've seen in the UK, they've found problems in people with severe allergic reactions."

CVS plans to give breastfeeding patients first doses of Pfizer's coronavirus vaccine on December 21

CVS expects to administer Pfizer's first COVID-19 vaccine to residents of long-term care facilities on December 21, followed by shots from Moderna about a week later, a CVS Health executive told Reuters.

Pfizer and BioNTech could get emergency approval for their COVID-19 vaccine from regulators as early as Friday. It was about a week ago that Moderna was regulated.

An FDA advisory committee on Thursday recommended that the agency approve Pfizer's shot in an emergency – but the FDA has yet to deregister, and the Secretary for Health and Human Services (HHS) Alex Azar said Friday it could "a couple Days "last.

Officials have announced that Pfizer and the US government will begin distributing the footage within 24 hours of receiving regulatory information. The hospitals plan to begin giving healthcare workers their first admissions early next week.

It will be a tight timeline to meet the expectations set by CVS. General Gustave Perna, co-head of Operation Warp Speed, said the US would have "gun shots" within 96 hours (four days) of FDA approval.

That means the FDA must approve Pfizer's shot by next Thursday when its committee meets to discuss Moderna's shot.

In order to distribute this vaccine in time for it to be delivered to nursing home residents by December 28, the FDA must approve it by Christmas Eve – a week after the meeting.

CVS expects to receive its first Pfizer dose allocation late next week, but will wait until December 21st to ensure compliance, said Chris Cox, senior vice president at CVS Health.

He said U.S. officials wanted to give nursing home admissions administrators time to review admission information documents and obtain waivers from nursing home residents and their families.

Some states are choosing to use Moderna's COVID-19 vaccine to vaccinate their nursing home residents rather than the Pfizer shot. The earliest time CVS Modernas can deliver shots to nursing home residents is December 28th.

Moderna has applied for an emergency permit and is expected to receive it soon after a meeting of advisors to the US Food and Drug Administration on December 17th.

CVS and Walgreens Boots Alliance, which operate the country's largest pharmacy chains but also provide other outside pharmacy services, have reached an agreement with the federal government to vaccinate nursing home residents across the country through a voluntary program.

Cox said he believes all states have chosen the federal program by that time and that CVS is working with 8,000 qualified care facilities across the country.

America's Deadliest Week: The number of COVID deaths rose 15,966 in the past seven days as the country posted a record 1.4 million new cases with 106,000 hospital residents – and the worst is to come

The United States has had its deadliest week of the coronavirus pandemic, with deaths rising 44 percent across the country from last week.

In the past seven days, the US has set new records in all three metrics that measure the severity of the pandemic, according to the COVID Tracking Project.

The death toll rose to 15,966 last week, the number of new cases to 1.4 million, and C0VID-19 hospital admissions to an all-time high of 107,248 after another new record was set Thursday.

A total of 2,768 Americans died yesterday after rising above 3,000 for the first time the day before. The number of infections reached 224,452 yesterday.

The average number of deaths reported this week has now surpassed the peak seen at the height of the pandemic last April.

There were 2,611 deaths as of April 30th as of last week when New York City was the epicenter of the nation's outbreak.

According to their data, the COVID Tracking Project warns that if the pattern continues, the worst will still come with the surge in cases leading to even more record-breaking daily deaths.

In the past seven days, the US has set new records in all three metrics that measure the severity of the pandemic, according to the COVID Tracking Project. The death toll rose to 15,966 last week, the number of new cases to 1.4 million, and C0VID-19 hospital admissions to an all-time high of 107,248 after another new record was set Thursday

In the past seven days, the US has set new records in all three metrics that measure the severity of the pandemic, according to the COVID Tracking Project. The death toll rose to 15,966 last week, the number of new cases to 1.4 million, and C0VID-19 hospital admissions to an all-time high of 107,248 after another new record was set Thursday

The U.S. has had its deadliest week of the coronavirus pandemic, with deaths rising 44 percent across the country from last week and Thursday. This is the second day in a row that more than 3,000 people have died

The U.S. has had its deadliest week of the coronavirus pandemic, with deaths rising 44 percent across the country from last week and Thursday. This is the second day in a row that more than 3,000 people have died

In the past week, weekly new cases increased by 27 percent and hospital stays increased by 8.8 percent, adding further strain to the country's medical system.

The U.S. has now reported more than 15.6 million coronavirus cases and 292,141 deaths.

While new cases have been recorded in the Midwest, which originally led to this third outbreak, falls are increasing sharply in the northeast, south and west.

Hospital stays are also starting to decline in many Midwestern states, but increasing in 26 other states and remaining the same in 12 other states.

California, Georgia, and states along the east coast saw the worst growth in hospital admissions last week.

New Hampshire was up 49 percent, Delaware was up 26 percent, and Maine was up 25 percent.

California also reported nearly 144,000 new cases this week, more than double the number in the second highest state, Texas, which has seen 71.8,000 new cases.

On Thursday, the US also broke the seven-day daily average for each of the three metrics, although new cases and deaths have declined since Wednesday.

The seven-day average for daily new cases is now 205,425 and for daily deaths it is 2,332.

Das COVID Tracking Project warnte erneut davor, dass noch höhere Todesraten bevorstehen könnten, da nur zwei Staaten am Donnerstag Rekordtodesfälle an einem Tag meldeten, während ihre Fälle weiter zunehmen.

Todesfälle durch COVID-19 können in einigen Fällen nach einem Anstieg ein verzögerter Faktor sein.

In der letzten Woche nahmen die wöchentlichen Neuerkrankungen um 27 Prozent und die Krankenhausaufenthalte um 8,8 Prozent zu, was das medizinische System des Landes weiter belastete. Im Bild untersuchen Mitarbeiter einen Patienten auf der Intensivstation in Texas

In der letzten Woche nahmen die wöchentlichen Neuerkrankungen um 27 Prozent und die Krankenhausaufenthalte um 8,8 Prozent zu, was das medizinische System des Landes weiter belastete. Im Bild untersuchen Mitarbeiter einen Patienten auf der Intensivstation in Texas

Nach Angaben der Zentren für die Kontrolle von Krankheiten wurden in den letzten sieben Tagen in Nord- und Süddakota, Rhode Island und Iowa die meisten Todesfälle pro Kopf verzeichnet.

Sie alle meldeten in der vergangenen Woche mehr als zwei Todesfälle pro 100.000 Einwohner.

Es gab zehn Staaten, die am Donnerstag über 10.000 neue tägliche Fälle meldeten, darunter Kalifornien mit 29.6777 neuen Fällen, Texas mit 12.458 neuen Fällen und Pennsylvania mit 11.972 neuen Fällen.

Kalifornien war der einzige Staat, der über 20.000 meldete.

Mit 948 neuen Fällen am Donnerstag hat Rhode Island jetzt mit 1.150 Fällen pro Million Menschen den höchsten Pro-Kopf-Durchschnitt von sieben Tagen in neuen täglichen Fällen.

Es folgen North Dakota mit 1.050 neuen täglichen Fällen pro Million Einwohner und Ohio mit 1.039 neuen täglichen Fällen pro Million Einwohner.

Laut dem COVID Tracking-Projekt verzeichnet Rhode Island einen beunruhigenden Anstieg der Fälle in der Latino-Community.

Mehr als 1 von 8 Latinx-Personen haben positiv auf COVID-19 getestet, verglichen mit 1 von 31 Weißen im Bundesstaat in der vergangenen Woche.

In South Dakota sind die amerikanischen Ureinwohner am stärksten betroffen, da jeder siebte Test positiv auf COVID-19 getestet wurde.

Die Krise im ganzen Land bringt die medizinischen Zentren an den Rand der Krise und lässt Mitarbeiter und Beamte des öffentlichen Gesundheitswesens ausgebrannt und von Tränen und Albträumen geplagt werden.

Das Ministerium für Gesundheit und menschliche Dienste (HHS) hat Anfang dieser Woche erstmals seit Beginn der Pandemie Daten auf Einrichtungsebene aus mehr als 2.000 Landkreisen veröffentlicht. Dies zeigt, dass sich die Krankenhausbetten jetzt viel schneller als erwartet füllen.

Laut einer CNN-Analyse war eine von drei Intensivstationen im ganzen Land in der vergangenen Woche zu mehr als 90 Prozent voll.

Darüber hinaus hatten mindestens 200 Krankenhäuser in keiner Einheit mehr Betten zur Verfügung, was darauf hinweist, dass medizinische Zentren in allen Regionen der USA möglicherweise bald an ihren Bruchstellen stehen.

Laut CNN besetzten Coronavirus-Patienten in der ersten Novemberwoche 19 Prozent der stationären Betten und 37 Prozent der Intensivbetten.

In der ersten Dezemberwoche stiegen beide Zahlen auf 28 Prozent bzw. 46 Prozent.

Eine andere Analyse des COVID-19 Hospitalization Tracking Project der University of Minnesota ergab, dass Krankenhäuser in 126 Landkreisen zu mindestens 90 Prozent voll waren, berichtete NPR.

Die Staaten mit den meisten Landkreisen, die diese Benchmark erreichten, waren Georgia, Kentucky, Minnesota, Oklahoma und Texas.

Es kommt auch, als neue Daten des Center for Disease Control zeigten, dass die tatsächliche Anzahl von COVID-19-Fällen in den USA viel höher sein könnte als die aktuellen Zahlen mit nur einer von sieben Infektionen, von denen angenommen wird, dass sie gemeldet wurden.

Wie wird der Pfizer COVID-Impfstoff in den USA vertrieben?

Die Bundesregierung bereitet die Auslieferung von Millionen Dosen des Pfizer COVID-Impfstoffs vor, nachdem er am Freitag von der FDA zugelassen wurde.

Der Sekretär für Gesundheit und menschliche Dienste, Alex Azar, sagte, die USA könnten 20 Millionen Dosen pro Monat erhalten.

Laut Pfizer ist der Impfstoff, den das Unternehmen zusammen mit dem deutschen Partner BioNTech SE entwickelt hat, zu 90 Prozent gegen COVID-19 wirksam. Es wird erwartet, dass bereits nächste Woche Sicherheitsdaten vorliegen, um eine Genehmigung für den Notfall zu beantragen.

Dr. Anthony Fauci, basierend auf den ersten Erkenntnissen von Pfizer, sagte, er erwarte, dass die Dosen des Impfstoffs im Dezember für bestimmte Gruppen mit hoher Priorität verfügbar sein werden und dass die allgemeine Bevölkerung den Impfstoff bis April erhalten könnte.

Massive vaccine campaigns are nothing new but stamping out the coronavirus is a distinctly new challenge due to three factors: The short time frame for vaccinating a huge number of people, the fact that most vaccines will require two doses and the very low temperature at which some of the vaccines must be stored. Pfizer's vaccine needs to be stored at -94 degrees Farenheit.

So with all the positive news of potential vaccine breakthroughs, what is the government's plan to effectively distribute the jab to Americans once it's available?

The efforts to provide vaccinations to 300 million Americans is being led by US Army general Gus Perna, who has been put in charge of Operation Warp Speed – the program created by the Trump administration to produce and coordinate the distribution of the COVID-19 vaccine.

Here's what we know so far:

The US government plans to start vaccinating Americans next month if Pfizer has its COVID-19 vaccine approved by Food and Drug Administration health regulators as quickly as expected

The US government plans to start vaccinating Americans next month if Pfizer has its COVID-19 vaccine approved by Food and Drug Administration health regulators as quickly as expected

Who will get the vaccine first and when will it be rolled out?

HHS secretary Alex Azar offered up a timeline on Tuesday regarding who would be the first to receive the COVID-19 vaccination if they can start rolling out the jabs next month as planned.

The elderly in nursing homes and assisted living facilities will likely be the first to the vaccinated.

Adults with underlying medical conditions that put them at risk of severe COVID-19 illness and people over 65 years of age could also fall into this initial category, according to  according to Operation Warp Speed's strategy plan.

Inoculations of healthcare workers and first responders will follow, with a goal to complete those shots by the end of January.

Azar said he expects to have enough vaccinations for 'all Americans' by the end of March to early April.

A final priority list is still being determined by the CDC's Advisory Committee on Immunization Practices that will based, in part, on vaccine efficacy data from the various trials, including Pfizer and Moderna.

How many shots will you have to get and how much will it cost?

The COVID-19 vaccine will need to be taken in two doses about three weeks apart to be fully effective.

While there could be multiple vaccines available by next year, they are not interchangeable if they have been developed by different companies.

This means the second dose needs to be from the same manufacturer as the first dose.

Operation Warp Speed's strategy plan details that those providing the vaccine should be giving out vaccine record cards that details the manufacturer. Record cards can also serve as a reminder about getting the second dose.

Congress and President Donald Trump have already enacted legislation that calls for the vaccines to be free to all Americans.

HHS secretary Alex Azar offered up a timeline on Tuesday regarding who would be the first to receive the COVID-19 vaccination if they can start rolling out the jabs next month as planned

How many will the US have available?

The government already has a $1.95 billion contract for 100 million doses of the Pfizer vaccine, which is enough to inoculate 50 million people, with an option to acquire 500 million more.

The government also anticipates vaccines from other companies soon, including Moderna Inc, which is expected to announce interim results of its vaccine trial at the end of the month.

The government will also secure 100 million doses of Moderna's vaccine after paying $1.5 billion.

Where will Americans be able to get COVID-19 vaccinations?

The government will be allocating vaccine supplies to states which will then be responsible for administering the jabs.

The government is organizing a free distribution of the vaccine to US states and territories, with each jurisdiction to decide how to distribute the doses to hospitals, pharmacies, doctors or even universities.

In the early stages of the roll out, the CDC has recommended that states make vaccines available at large hospitals and health systems, pharmacies, mobile vaccination providers, occupational health settings for large employers, critical access hospitals, rural health clinics, community health centers and other central locations that can provide vaccination services for a broad area.

The CDC says it has existing agreements with CVS and Walgreens to assist with on-site vaccinations at long-term care facilities.

Operation Warp Speed has indicated they want vaccinations to be available at all healthcare professionals who are licensed to administer vaccines, including pharmacies.

The pharmacies that have already signed on to provide vaccinations, according to the CDC, include: Walgreens, CVS, Walmart, Rite Aid, Kroger Co., Albertsons and Costco.

Pfizer has already created a staging ground at its Michigan facility (pictured above) complete with 350 large freezers to hold the vaccines, which need to be stored at -94F, once they're created and ready to ship

Pfizer has already created a staging ground at its Michigan facility (pictured above) complete with 350 large freezers to hold the vaccines, which need to be stored at -94F, once they're created and ready to ship

The Trump administration has paid $1.95 billion for 100 million initial doses of the Pfizer vaccine. Pfizer says it could have up to 50 million doses available by the end of this year if approved

The Trump administration has paid $1.95 billion for 100 million initial doses of the Pfizer vaccine. Pfizer says it could have up to 50 million doses available by the end of this year if approved

Who is in charge of shipping out the vaccinations and how will they be handled?

While US Army general Gus Perna is coordinating the distribution of the vaccine, the military will not be involved in shipping out the vaccine to the locations where the jabs will be administered.

Vaccines made by Moderna and other candidates will be shipped directly from the manufacturer by medical supply company McKesson Corp.

McKesson, who has been contracted by Operation Warp Speed for distribution, was also contracted by the government to distribute H1N1 vaccines during that pandemic in 2009-2010.

Pfizer has already said it will distribute its own vaccine from its facilities in Kalamazoo, Michigan and Pleasant Prairie, Wisconsin.

The drugmaker has already created a staging ground at its Michigan facility complete with 350 large freezers to hold the vaccines once they're created and ready to ship.

Pfizer's ship-out will include a precise, clockwork-like dance of containers, trucks and planes.

The vaccine needs to be stored at -94 degrees Fahrenheit, so thermal shipping containers will each be filled with dry ice and 975 vials of the vaccine which each contain five doses, for a total of 4,875 doses.

Every day six trucks will take the doses to air carriers such as FedEx, UPS or DHL, which will deliver them across the US in one to two days and across the globe in three.

The company expects an average of 20 daily cargo flights worldwide.

FedEx had to obtain special permission from civil aviation authorities to transport so much dry ice, which could pose a danger to the crew should it accidentally undergo 'sublimation' and pass from a solid to a gas, the company

Once the boxes have reached their final destination, they can be opened only briefly just two times a day. The vaccines can remain in their boxes for two weeks meaning hospitals will not need a special freezer.

Moderna's vaccine can be stored at -4 degrees Fahrenheit, which is the temperature of a normal freezer.

.(tagsToTranslate)dailymail(t)news(t)Pfizer(t)Coronavirus